Arteriolar insulin resistance in a rat model of polycystic ovary syndrome

Fertility and Sterility

Volumn 97, Issue 2, 2012, Pages 462-468

  Sara, Levente ^a   Antal, Peter ^a   Masszi, Gabriella ^b   Buday, Anna ^a   Horvath, Eszter M ^a   Hamar, Peter ^a   Monos, Emil ^a   Nadasy, Gyorgy L ^a   Varbiro, Szabolcs ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b BAJCSY ZSILINSZKY HOSPITAL   (Hungary)

Author keywords

arteriole; PCOS; vascular insulin resistance; vitamin D

Indexed keywords

ACETYLCHOLINE; ANDROSTANOLONE; CALCITRIOL; GLUCOSE; INSULIN; NITRIC OXIDE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOGRAPHY; ARTERIOLE; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; NONHUMAN; OVARY POLYCYSTIC DISEASE; PRESSURE ARTERIOGRAPHY; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ANIMALS; ARTERIOLES; BLOOD GLUCOSE; CHOLECALCIFEROL; DIHYDROTESTOSTERONE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; MUSCLE, SKELETAL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POLYCYSTIC OVARY SYNDROME; RATS; RATS, WISTAR; VASODILATION; VASODILATOR AGENTS;

EID: 84856376727     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.11.015     Document Type: Article

References (41)

1. R. Hart, D.A. Doherty, T. Mori, R.C. Huang, R.J. Norman, and S. Franks Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome Fertil Steril 95 2011 2347 2353
2. A. Dokras Cardiovascular disease risk factors in polycystic ovary syndrome Semin Reprod Med 26 2008 39 44
3. K. Lakhani, N. Constantinovici, W.M. Purcell, R. Fernando, and P. Hardiman Internal carotid artery haemodynamics in women with polycystic ovaries Clin Sci 98 2000 661 665 (Pubitemid 30386428)
4. C. Meyer, B.P. McGrath, and H.J. Teede Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease J Clin Endoc Metab 90 2005 5711 5716 (Pubitemid 41415480)
5. K. Lakhani, A. Leonard, A.M. Seifalian, and P. Hardiman Microvascular dysfunction in women with polycystic ovary syndrome Hum Reprod 20 2005 3219 3224 (Pubitemid 41662682)
6. N. Agarwal, S.P. Rice, H. Bolusani, S.D. Luzio, G. Dunseath, and M. Ludgate Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial J Clin Endocr Metab 95 2010 722 730
7. K.K. Naka, S.N. Kalantaridou, M. Kravariti, A. Bechlioulis, N. Kazakos, and K.A. Calis Effect of the insulin sensitizers Metformin and Pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study Fertil Steril 95 2011 203 209
8. S. Thys-Jacobs, D. Donovan, A. Papadopoulos, P. Sarrel, and J.P. Bilezikian Vitamin D and calcium dysregulation in the polycystic ovarian syndrome Steroids 64 1999 430 435 (Pubitemid 29340525)
9. Y.F. Yiu, Y.H. Chan, K.H. Yiu, C.W. Siu, S.W. Li, and L.Y. Wong Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes J Clin Endocr Metab 96 2011 E830 E835
10. K. Kotsa, M.P. Yavropoulou, O. Anastasiou, and J.G. Yovos Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome Fertil Steril 92 2009 1053 1058
11. M.S. Wong, R. Delansorne, R.Y. Man, P. Svenningsen, and P.M. Vanhoutte Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat Am J Physiol Heart Circ Physiol 299 2010 H1226 H1234
12. R. Przybylski, S. McCune, B. Hollis, and R.U. Simpson Vitamin D deficiency in the spontaneously hypertensive heart failure (SHHF) prone rat Nutr Metab Cardiovas 20 2010 641 646
13. L. Manners, S. Cajander, A. Holmang, Z. Seleskovic, T. Lystig, and M. Lönn A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome Endocrinology 148 2007 3781 3791 (Pubitemid 47105840)
14. L.L. Yanes, D.G. Romero, M. Moulana, R. Lima, D.D. Davis, and H. Zhang Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome Gender Medicine 8 2011 103 115
15. Y. Pan, B. Cai, K. Wang, S. Wang, S. Zhou, and X. Yu Neferine enhances insulin sensitivity in insulin resistant rats J Ethnopharmacol 124 2009 98 102
16. K.C. Marchand, E.J. Arany, and D.J. Hill Effects of atorvastatin on the regeneration of pancreatic β-cells after streptozotocin treatment in the neonatal rodent Am J Physiol Endocr Metab 299 2010 E92 E100
17. B.K. Tan, J. Chen, J.E. Digby, S.D. Keay, C.R. Kennedy, and H.S. Randeva Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome Diabetologia 49 2006 2723 2728
18. B. Trolle, F.F. Lauszus, J. Frystyk, and A. Flyvbjerg Adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a randomized controlled study Fertil Steril 94 2010 2234 2238
19. 2+ channel blockade Endocrinology 149 2008 2517 2526 (Pubitemid 351574497)
20. C. Castillo, E.F. Castillo, J. López, and R.M. López Testosterone inhibits the contractile responses to phenylephrine associated with the release of intracellular calcium in rat aorta Gac Med Mex 142 2006 1 8
21. K.K. Miller, B.M.K. Biller, A. Schaub, K. Pulaski-Liebert, G. Bradwin, N. Rifai, and A. Klibanski Effects of testosterone therapy on cardiovascular risk markers in androgen-deficient women with hypopituitarism J Clin Endocr Metab 92 2007 2474 2479 (Pubitemid 47037345)
22. A. Cornoldi, G. Caminiti, G. Marazzi, C. Vitale, R. Patrizi, and M. Volterrani Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease Int J Cardiol 142 2010 50 55
23. M.R. Adams, J.K. Williams, and J.R. Kaplan Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness Arterioscler Thromb Vasc Biol 15 1995 562 570
24. E. Diamanti-Kandarakis, K. Alexandraki, C. Piperi, A. Protogerou, I. Katsikis, and T. Paterakis Inflammatory and endothelial markers in women with polycystic ovary syndrome Eur J Clin Invest 36 2006 691 697 (Pubitemid 44393927)
25. Z. Soyman, V. Noyan, M. Tulmac, A. Yucel, N. Sagsoz, and T. Bayrak Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery flow-mediated dilatation in women with polycystic ovary syndrome Fertil Steril 95 2011 1067 1072
26. C. Meyer, B.P. McGrath, and H.J. Teede Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome Diabetes Care 30 2007 471 478 (Pubitemid 46354320)
27. H.J. Teede, C. Meyer, S.K. Hutchison, S. Zoungas, B.P. McGrath, and L.J. Moran Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy Fertil Steril 93 2010 184 191
28. F. Orio, S. Palomba, T. Cascella, B. De Simone, F. Manguso, and S. Savastano Improvement in endothelial structure and function after Metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study J Clin Endocr Metab 90 2005 6072 6076 (Pubitemid 41606527)
29. M. Jensterle, M. Sebestjen, A. Janez, J. Prezelj, T. Kocjan, and I. Keber Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome Eur J Endocrinol 159 2008 399 406
30. H.O. Steinberg, G. Brechtel, A. Johnson, N. Fireberg, and A.D. Baron Insulin-mediated skeletal muscle vasodilatation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release J Clin Invest 94 1994 1172 1179
31. U. Scherrer, D. Randin, P. Vollenweider, L. Vollenweider, and P. Nicod Nitric oxide release accounts for insulin's vascular effects in humans J Clin Invest 94 1994 2511 2515 (Pubitemid 24379629)
32. C.J. Tack, J.A. Lutterman, G. Vervoot, T. Thien, and P. Smits Activation of the sodium-potassium pump contributes to insulin-induced vasodilatation in humans Hypertension 28 1996 426 432 (Pubitemid 26296046)
33. H. Yki-Järvinen, and T. Utriainen Insulin-induced vasodilatation: physiology or pharmacology? Diabetologia 41 1998 369 379 (Pubitemid 28157407)
34. A. Luis, L.A. Juncos, and S. Ito Disparate effects of insulin on isolated rabbit afferent and efferent arterioles J Clin Invest 92 1993 1981 1985 (Pubitemid 23304568)
35. 2+) channels Eur J Pharmacol 652 2011 89 95
36. R.J. Gonzales, A.A. Ghaffari, S.P. Duckles, and D.N. Krause Testosterone treatment increases thromboxane function in rat cerebral arteries Am J Physiol Heart Circ Physiol 289 2005 H578 H585
37. A. Gericke, J.J. Sniatecki, V.G. Mayer, E. Goloborodko, A. Patzak, and J. Wess Role of M1, M3, and M5 muscarinic acetylcholine receptors in cholinergic dilation of small arteries studied with gene-targeted mice Am J Physiol Heart Circ Physiol 300 2011 H1602 H1608
38. J.D. Peuler, B.A. Johnson, S.M. Phare, and J.R. Sowers Sex-specific effects of an insulin secretagogue in stroke-prone hypertensive rats Hypertension 22 1993 214 220 (Pubitemid 23234068)
39. D.T. Ngo, W.P. Chan, S. Rajendran, T. Heresztyn, A. Amarasekera, and A.L. Sverdlov Determinants of insulin responsiveness in young women: impact of polycystic ovarian syndrome, nitric oxide, and vitamin D Nitric Oxide 25 2011 326 330
40. D. Somjen, G.H. Posner, and N. Stern Less calcemic vitamin D analogs enhance creatine kinase specific activity and modulate responsiveness to gonadal steroids in the vasculature J Steroid Biochem 101 2006 232 238 (Pubitemid 44573807)
41. A. Cardus, S. Panizo, M. Encinas, X. Dolcet, C. Gallego, and M. Aldea 1,25-Dihydroxyvitamin D3 Regulates VEGF production through a vitamin D response element in the VEGF promoter Atherosclerosis 204 2009 85 89